A Phase I Study of LY3502970 in Healthy Participants

NCT06085482 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3502970
DRUG: [14C]-LY3502970

Sponsor

Eli Lilly and Company